59 related articles for article (PubMed ID: 12821587)
1. Clinical outcomes with Biolimus (A9)™ eluting stent, 'BioMatrix' in diabetic patients--interim results from multicenter post market surveillance registry in India.
Seth A; Hiremath S; Dani S; Kapoor S; Jain RK; Abhaichand R; Trivedi S; Kaul U; Patil A; Khemnar B; Rangnekar H
Indian Heart J; 2013; 65(5):586-92. PubMed ID: 24206882
[TBL] [Abstract][Full Text] [Related]
2. Crush stenting with drug-eluting stents: relevance of coronary bifurcation lesion location on angiographic and clinical outcomes.
Chen SL; Zhang JJ; Ye F; Liu ZZ; Zhu ZS; Lin S; Tian NL; Fang WY; Chen YD; Sun XW; Wei M; Shan SJ; Kan J; Qian J; Yang S; Yuan ZB; Kwan TW; Hu DY
Clin Cardiol; 2010 Dec; 33(12):E32-9. PubMed ID: 20857513
[TBL] [Abstract][Full Text] [Related]
3. Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate.
Dietz U; Dauer C; Lambertz H
Exp Clin Cardiol; 2006; 11(4):294-7. PubMed ID: 18651020
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model.
Hong YJ; Jeong MH; Lee SR; Hong SN; Kim KH; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
J Korean Med Sci; 2007 Oct; 22(5):802-9. PubMed ID: 17982226
[TBL] [Abstract][Full Text] [Related]
5. Issues in the acquisition, development, and use of technology in health care.
Lanzafame RJ
JSLS; 2006; 10(4):401-8. PubMed ID: 17575747
[No Abstract] [Full Text] [Related]
6. Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate.
Dietz U; Dauer C; Lambertz H
Curr Control Trials Cardiovasc Med; 2005 Dec; 6(1):18. PubMed ID: 16351730
[TBL] [Abstract][Full Text] [Related]
7. Systemic inflammation after drug-eluting stent placement.
Gogo PB; Schneider DJ; Watkins MW; Terrien EF; Sobel BE; Dauerman HL
J Thromb Thrombolysis; 2005 Apr; 19(2):87-92. PubMed ID: 16052297
[TBL] [Abstract][Full Text] [Related]
8. Analysis of prosthetic cardiac devices: a guide for the practising pathologist.
Butany J; Collins MJ
J Clin Pathol; 2005 Feb; 58(2):113-24. PubMed ID: 15677529
[TBL] [Abstract][Full Text] [Related]
9. [When are drug-eluting stents effective? A critical analysis of the presently available data].
Silber S
Z Kardiol; 2004 Sep; 93(9):649-63. PubMed ID: 15365732
[TBL] [Abstract][Full Text] [Related]
10. New approaches to preventing restenosis.
Bhargava B; Karthikeyan G; Abizaid AS; Mehran R
BMJ; 2003 Aug; 327(7409):274-9. PubMed ID: 12896943
[TBL] [Abstract][Full Text] [Related]
11. Drug-eluting stents: new era and new concerns.
Bhatia V; Bhatia R; Dhindsa M
Postgrad Med J; 2004 Jan; 80(939):13-8. PubMed ID: 14760171
[TBL] [Abstract][Full Text] [Related]
12. Drug eluting stents: maximising benefit and minimising cost.
Gunn J; Morton AC; Wales C; Newman CM; Crossman DC; Cumberland DC
Heart; 2003 Feb; 89(2):127-31. PubMed ID: 12527654
[TBL] [Abstract][Full Text] [Related]
13. Coronary brachytherapy in the drug-eluting stent era: don't bury it alive.
Waksman R; Weinberger J
Circulation; 2003 Jul; 108(4):386-8. PubMed ID: 12885731
[No Abstract] [Full Text] [Related]
14. Drug-eluting stents: costs versus clinical benefit.
O'Neill WW; Leon MB
Circulation; 2003 Jun; 107(24):3008-11. PubMed ID: 12821587
[No Abstract] [Full Text] [Related]
15. Drug-eluting stents: cost versus clinical benefit.
Lemos PA; Serruys PW; Sousa JE
Circulation; 2003 Jun; 107(24):3003-7. PubMed ID: 12821586
[No Abstract] [Full Text] [Related]
16. Hippocrates revisited: the evidence for drug-eluting stents.
Kereiakes DJ
Circulation; 2003 Jun; 107(24):3012-4. PubMed ID: 12821588
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
